ZHOU Yue, FU Xuemei, ZHANG Lin, SONG Li, KANG Shufang.
Objective To explore the curative efficacy of transcervical resection of polyp (TCRP) combined with levonorgestrel-releasing intrauterine system (LNG-IUS), and its influences on serum sex hormones and recurrence. Methods A retrospective analysis was performed on the clinical data of 280 patients with endometrial polyps (EP) who underwent TCRP from March 2022 to September 2023. According to presence or absence of LNG-IUS, patients were divided into LNG-IUS group (n=141) and control group (n=139). All were followed up for 12 months after surgery. The endometrial thickness, menstrual volume pictorial blood loss assessment chart (PBAC), uterine hemodynamics pulsatility index (PI), and resistance index (RI), levels of serum vascular endothelial growth factor (VEGF), luteinizing hormone (LH), and follicle stimulating hormone (FSH) were compared between the two groups, and recurrence rate was observed by follow-up. Results At 3, 6 and 12 months after surgery, endometrial thickness in LNG-IUS group was lower than that in control group (P<0.05), PBAC scores were lower than those in control group (P<0.05), and levels of serum VEGF, LH and FSH were lower than those in control group (P<0.05). At 12 months after surgery, PI and RI in LNG-IUS group were lower than those in control group (P<0.05). At 12 months after surgery, there were 2 recurrence cases (1.42%) in LNG-IUS group and 11 recurrence cases (7.91%) in control group, respectively. The recurrence rate in LNG-IUS group was lower than that in control group (χ2=6.670, P<0.05). Conclusions Hysteroscopic surgery combined with postoperative progesterone therapy is beneficial to reduce endometrial thickness, menstrual blood loss and risk of postoperative recurrence in patients with endometrial polyps, which has high safety.